Vical Incorporated (Nasdaq: VICL) today announced a restructuring to conserve capital and to focus its efforts on VL-2397, its antifungal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE